Back to Pradaxa

Pradaxa (Dabigatran) Capsule Uses in Pakistan

Pradaxa (dabigatran etexilate 75/110/150mg) is a prescription direct thrombin inhibitor anticoagulant used in Pakistan. This guide covers its approved uses and critical safety information.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Uses

Quick Answer

Pradaxa (dabigatran etexilate) is used to prevent stroke and blood clots in atrial fibrillation, to treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and to prevent recurrence of DVT/PE. It is a direct thrombin inhibitor anticoagulant. It carries a HIGH RISK of serious bleeding. Always use under strict medical supervision.

Primary Uses at a Glance

Stroke Prevention in Non-Valvular Atrial Fibrillation (AF)

Pradaxa (dabigatran) is used to reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors. This is the primary approved indication in Pakistan.

As prescribed by your cardiologist or physician after cardiac evaluation.

Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

Pradaxa is used to treat acute DVT (blood clot in leg vein) and PE (blood clot in lung) after initial parenteral anticoagulation. This is one of the primary approved indications in Pakistan.

As prescribed by your doctor following initial anticoagulation therapy.

Prevention of Recurrent DVT and PE

Pradaxa is used to prevent recurrence of deep vein thrombosis and pulmonary embolism in patients who have previously been treated for these conditions.

As prescribed by your doctor for secondary prevention after completing initial DVT/PE treatment.

Other Uses

  • Prevention of DVT/PE after hip or knee replacement surgery

Pradaxa Capsule Uses (Fayde / Kis kaam aata hai)

HIGH RISK MEDICINE: Pradaxa (dabigatran) is an anticoagulant (blood thinner). It carries a serious risk of life-threatening bleeding. Use ONLY under strict medical supervision. Do not start, stop, or change the dose without your doctor's advice.

Pradaxa contains dabigatran etexilate and belongs to the Direct Thrombin Inhibitor (DOAC) group of anticoagulants. Below are all the approved uses of Pradaxa in Pakistan.

Primary Uses (Mukhya Istemal)

  • Stroke and systemic embolism prevention in non-valvular atrial fibrillation (AF)
  • Treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE)
  • Prevention of recurrent DVT and PE

Who Should Take It (Kin logon ke liye)

  • Adult patients with non-valvular atrial fibrillation (AF) at risk of stroke
  • Patients with confirmed acute DVT or PE (after initial anticoagulation therapy)
  • Patients who have had DVT/PE and need prevention of recurrence

When NOT to Use Pradaxa (Kab nahi lena chahiye)

  • If you are allergic to dabigatran etexilate or any ingredient in Pradaxa
  • If you have active serious bleeding (e.g., gastric ulcer, intracranial hemorrhage)
  • If you have severe kidney disease (CrCl < 30 mL/min) — contraindicated
  • If you have prosthetic heart valves requiring anticoagulation
  • If you are pregnant or breastfeeding

Summary

Pradaxa is prescribed for stroke prevention in AF and DVT/PE treatment and prevention. It is a HIGH RISK anticoagulant requiring strict medical supervision, regular renal function monitoring, and is NEVER to be stopped abruptly without your doctor's advice.

The information in this guide is for educational purposes only.

Frequently Asked Questions

Pradaxa (dabigatran) kis kaam aata hai?

Pradaxa is used to prevent stroke in patients with atrial fibrillation, and to treat and prevent recurrence of deep vein thrombosis and pulmonary embolism. It is a HIGH RISK blood-thinning medicine that must be used only under strict medical supervision.

Can Pradaxa be taken without a doctor's prescription?

No. Pradaxa is a HIGH RISK prescription anticoagulant. Taking it without a prescription significantly increases the risk of life-threatening bleeding. Always use under a doctor's supervision with regular monitoring.

How long does Pradaxa take to show results?

Pradaxa reaches peak blood levels within 1-3 hours of taking a dose. Its anticoagulant effect begins quickly. Your doctor will assess therapeutic adequacy through clinical monitoring.

Can Pradaxa be taken long-term?

Yes, Pradaxa may be prescribed for long-term use especially for AF stroke prevention. Duration is determined by your doctor based on your condition and bleeding risk assessment.

What should I do if Pradaxa does not seem to control my symptoms?

If you experience new symptoms of stroke or blood clot while on Pradaxa, seek emergency medical help immediately. Never stop or adjust the dose yourself without your doctor's guidance.

Sources

  1. DRAP Registered Products Database Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) World Health Organization
  3. British National Formulary (BNF) BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.